Who is sponsoring TEMPEST?

TEMPEST is sponsored by Johns Hopkins University.

What condition does TEMPEST study?

TEMPEST studies Post-surgical Cystoid Macular Edema (PSCME).

What is the status of TEMPEST?

TEMPEST is currently COMPLETED.

Last reviewed 2017-08-18 · How we verify

Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1)

NCT01769352 Phase 2/Phase 3 COMPLETED Results posted

The purpose of this study is to compare the change in visual acuity of patients with post surgical cystoid macular edema who will be treated with two different regimens.

Details

Lead sponsor	Johns Hopkins University
Phase	Phase 2/Phase 3
Status	COMPLETED
Enrolment	42
Start date	2012-08
Completion	2016-04

Conditions

Post-surgical Cystoid Macular Edema (PSCME)

Interventions

PredA + Kelac

Primary outcomes

Mean Change in Best-Corrected Visual Acuity at Week 12 From Baseline — Baseline and Week 12
Mean change in best-corrected visual acuity (Letter Score) at Week 12 from Baseline. The Early Treatment of Diabetic Retinopathy Study (ETDRS) score is measured on a scale from 5 to 100. The higher the score on this scale, the better is the patients vision.

Countries

United States